Tracking how infections spread in hospitals using genomic methods
Genomic methods for studying microbial transmission in healthcare settings
This study is looking at how whole-genome sequencing can help us understand how infections spread in hospitals, so we can better protect patients and improve safety for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10772149 on NIH RePORTER |
What this research studies
This research investigates how whole-genome sequencing (WGS) can be utilized to track the transmission of infections within healthcare settings. By analyzing genomic data, the study aims to identify connections between patients, hospital locations, and healthcare personnel that contribute to the spread of pathogens. The integration of genomic and clinical data will help uncover factors influencing infection rates and improve infection prevention strategies. The research addresses challenges related to antibiotic resistance and aims to enhance our understanding of how infections are transmitted in hospitals.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients who have been diagnosed with infections in healthcare facilities, particularly those linked to antibiotic-resistant strains.
Not a fit: Patients who are not currently hospitalized or those with infections not related to healthcare settings may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective infection control measures in healthcare settings, ultimately reducing the spread of infections among patients.
How similar studies have performed: Previous research using genomic methods for tracking infections has shown promise, indicating that this approach could yield significant insights into infection transmission.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Snitkin, Evan — University of Michigan at Ann Arbor
- Study coordinator: Snitkin, Evan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.